Echo Street Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,900
Closed -$265K 471
2023
Q2
$265K Buy
+4,900
New +$256K ﹤0.01% 398
2022
Q3
Sell
-13,155
Closed -$490K 564
2022
Q2
$490K Buy
+13,155
New +$535K ﹤0.01% 324
2021
Q4
Sell
-10,422
Closed -$452K 634
2021
Q3
$452K Buy
+10,422
New +$461K ﹤0.01% 440

Other funds holding BSX

Echo Street Capital Management's BSX Position: Q3 2023 in Review

Echo Street Capital Management sold out of Boston Scientific (BSX) in Q3 2023, closing a stake of 4,900 shares — an estimated $265K sold.

Echo Street Capital Management first reported a position in BSX in Q3 2021 and held it in 3 quarters. The position peaked at $490K in Q2 2022. 1,057 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

  • Echo Street Capital Management reported no remaining Boston Scientific position as of Q3 2023 after selling out during the quarter.
  • Echo Street Capital Management sold 4,900 Boston Scientific shares in Q3 2023, an estimated $265K.
  • Echo Street Capital Management first reported a position in Boston Scientific in Q3 2021 and held it in 3 quarters.
  • Echo Street Capital Management's Boston Scientific position peaked at $490K in Q2 2022.
  • 1,057 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on Echo Street Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.